Pharmacotherapy of comorbid mood, anxiety, and substance use disorders

被引：29
|
作者：
Brady, KT [1 ]
Verduin, ML [1 ]
机构：
[1] Med Univ S Carolina, Inst Psychiat, Charleston, SC 29425 USA
来源：
SUBSTANCE USE & MISUSE | 2005年 / 40卷 / 13-14期
关键词：
substance use; mood disorders; anxiety disorders; depression; bipolar disorder; panic disorder; post-traumatic stress disorder; obsessive compulsive disorder; social phobia; alcohol; cocaine; marijuana; opiates;
D O I：
10.1080/10826080500294924
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
Mood and anxiety disorders commonly co-occur with substance use disorders. Exploration of the neurobiology of substance use disorders and mood and anxiety disorders have found that the neural circuitry in mood, anxiety, and substance use disorders is clearly overlapping. These discoveries have encouraged the exploration of a number of pharmacotherapeutic agents in the treatment of co-occurring mood, anxiety, and substance use disorders. In this article, recent data on the pharmacotherapeutic treatment of mood and anxiety disorders in individuals with substance use disorders are reviewed. Some of the barriers to the use of pharmacotherapy in individuals with substance use disorders are discussed.
引用
收藏
页码：2021 / 2041
页数：21
相关论文
共 50 条
  • [41] COMORBID MOOD AND ANXIETY DISORDERS IN ADULT ADHD PATIENTS
    Meshkat, D.
    Kutzelnigg, A.
    Eckert, C.
    Konstantinidis, A.
    Kasper, S.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [42] Comorbid mood and anxiety disorders in adult ADHD patients
    Meshkat, D.
    Kutzelnigg, A.
    Eckert, C.
    Konstantinidis, A.
    Kasper, S.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2010, 14 : 28 - 29
  • [43] Treatment seeking and barriers to treatment for alcohol use in persons with alcohol use disorders and comorbid mood or anxiety disorders
    Kaufmann, Christopher N.
    Chen, Lian-Yu
    Crum, Rosa M.
    Mojtabai, Ramin
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2014, 49 (09) : 1489 - 1499
  • [44] Treatment seeking and barriers to treatment for alcohol use in persons with alcohol use disorders and comorbid mood or anxiety disorders
    Christopher N. Kaufmann
    Lian-Yu Chen
    Rosa M. Crum
    Ramin Mojtabai
    Social Psychiatry and Psychiatric Epidemiology, 2014, 49 : 1489 - 1499
  • [45] High Rates of Comorbid Anxiety and Substance Use Disorders in Early Bipolar Disorder
    Hasty, Melissa
    Macneil, Craig
    Cotton, Sue
    Daglas, Rothanthi
    Berk, Michael
    EARLY INTERVENTION IN PSYCHIATRY, 2016, 10 : 244 - 244
  • [46] Comorbid anxiety and mood disorders among persons with social anxiety disorder
    Erwin, BA
    Heimberg, RG
    Juster, H
    Mindlin, M
    BEHAVIOUR RESEARCH AND THERAPY, 2002, 40 (01) : 19 - 35
  • [47] Pharmacotherapy for Adolescents with Substance Use Disorders
    Courtney D.B.
    Milin R.
    Current Treatment Options in Psychiatry, 2015, 2 (3) : 312 - 325
  • [48] PHARMACOTHERAPY FOR ADOLESCENT SUBSTANCE USE DISORDERS
    Gray, Kevin M.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S85 - S85
  • [49] Pharmacotherapy for Substance Use Disorders in Youths
    Hammond, Christopher J.
    Gray, Kevin M.
    JOURNAL OF CHILD & ADOLESCENT SUBSTANCE ABUSE, 2016, 25 (04) : 292 - 316
  • [50] Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders - Findings from the Netherlands Mental Health Survey and Incidence Study
    de Graaf, R
    Bijl, RV
    Spijker, J
    Beekman, ATF
    Vollebergh, WAM
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2003, 38 (01) : 1 - 11
12345